Warning and Advisories for Healthcare Providers
>
Letters to Healthcare Providers
Letters to Healthcare Providers
Hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease (Letter to Healthcare Professionals)
Attachment:
Hyoscine butylbromide (Buscopan) injection: risk of serious adverse effects in patients with underlying cardiac disease
Related Information:
The United Kingdom: Hyoscine butylbromide (Buscopan) injection: risk of serious ...
Posted 2017-02-21